Skip to Menu Skip to Search Contact Us Global Websites & Languages Skip to Content

Welcome to Clinical Research News. Read our articles to stay ahead of current industry trends and key regulatory developments.

Displaying 41 articles

SGS Enrolls First Patient into Biophytis’ COVA Clinical Study, a COVID-19 Clinical Trial

This clinical trial examines a potential treatment for COVID-19 patients suffering from respiratory failure. Read More

  1. Life Sciences
September 02 2020

SGS’s Quality, Expertise & Reliability Recognized at CRO Leadership Awards 2020

We’re proud to be recognized for a fourth consecutive year with wins across five categories. Read More

  1. Life Sciences
July 16 2020

How to Address Clinical Research Challenges During COVID-19

Clinical Research in times of COVID-19 can bring new challenges. Read More

  1. Life Sciences
June 14 2020

SGS is Nominated in the 2020 Vaccine Industry Excellence Awards

Nominated by partners and stakeholders around the globe, SGS hopes to win this year’s Best Contract Research Organization at the ViE Awards. Read More

  1. Life Sciences
February 03 2020

SGS Life Sciences Shortlisted as Finalist in 2019 Clinical Research News European Innovations Awards

This nomination highlights our innovative H3N2 virus, which can be used for human challenge testing in our clinical pharmacology unit in Antwerp, Belgium. Read More

  1. Life Science Network News
August 22 2019

SGS Recognized at 2019 CRO Leadership Awards for the Third Successive Year

SGS today announced that it had been recognized in the annual CRO (Contract Research Organization) Leadership Awards. The wins came in five categories - Capabilities, Compatibility, Expertise, Quality, and Reliability. Read More

  1. Early Phase I-IIa
May 06 2019

SGS Implements Veeva Vault Clinical Trial Management System across its Global Network

The Vault CTMS system will enable SGS to share with its clients the state-of-the-art reporting capabilities and deliver greater flexibility in running studies. Read More

  1. Late Phase II-IV
April 29 2019

Novel Influenza Vaccine Clinical Trial Results Validate SGS’s H3N2 Challenge Agent

Preliminary data from a human challenge trial testing a FluGen vaccine against an SGS challenge agent reveal positive findings. Read More

  1. Early Phase I-IIa
March 11 2019

SGS to Conduct its First Malaria Human Challenge Trial in Belgium

This study will assist in the development of an advanced candidate compound from the antimalarial drug pipeline developed by MMV and partners. Read More

  1. Early Phase I-IIa
February 11 2019

SGS at World Vaccine Congress: Can Human Challenge Trials Show Upper-Respiratory Pathogen Immunity?

SGS will present “Inverse seroconversion following Live Influenza Virus challenge” at the upcoming World Vaccine Congress in Lisbon, Portugal, on October 30 2018. Read More

  1. Early Phase I-IIa
October 17 2018